Lymphocyte defect in plasmacytoma-bearing mice

Area of Science:

• Immunology
• Cancer Biology

Background:

• Multiple myeloma is frequently linked to humoral immunodepression in humans and mice.
• Plasmacytomas, a type of tumor, are used to study immune responses in mice.

Purpose of the Study:

• To investigate the impact of different plasmacytomas on humoral immunity and spleen lymphocyte responses in mice.
• To analyze the in vitro lymphocyte proliferation and T-cell responses in mice bearing various plasmacytomas.

Main Methods:

• Mice bearing specific plasmacytomas (TEPC-183, SPQC-11, MPC-11, MOPC-315) were immunized with sheep red blood cells (SRBC).
• Serum hemolysin levels, spleen lymphocyte counts, and lymphocyte proliferation (using PHA and LPS stimulation with TdR incorporation) were measured.

Main Results:

• Mice with TEPC-183 and SPQC-11 showed reduced antibody responses to SRBC and impaired lymphocyte proliferation.
• Mice with MPC-11 had normal antibody responses, while MOPC-315 mice had altered lymphocyte counts and proliferation.
• Defects in lymphocyte response to LPS in vitro correlated with impaired in vivo immune responses.

Conclusions:

• Different plasmacytomas exert varying degrees of immunodepression.
• The study highlights a correlation between impaired lymphocyte proliferation and reduced antibody production in mice with specific plasmacytomas.
• No immunosuppressive properties were detected in the serum of plasmacytoma-bearing mice.